AZD0466 GLOBAL TRIAL HAS BEGAN UPDATE, page-5

not thinking this anything new? as they were going to expand this world wide, but as indicated here not recruiting in the other site outside the US, no doubt covid.

i actually find the Merck & Co., Inc., (MSD) to conduct a preclinical
research evaluation of dendrimer-based Antibody Drug Conjugates (ADCs) utilising
Starpharma’s DEP® technology, more interesting as Merck seem to be align itself with ADC companies, but limited to the following activity by them......
if you look to Merck in this deal, an assumption could be to use Dep in conjunction.
https://www.biopharma-reporter.com/Article/2020/11/05/Merck-to-acquire-VelosBio-gains-antibody-drug-conjugate